Evogene Schedules Third Quarter Financial Results
Evogene Ltd. (Nasdaq: EVGN), a renowned computational biology company, has announced an important upcoming event for stakeholders. The company is set to disclose its financial results for the third quarter of 2024.
Conference Call Details
On the day of the release, a conference call will take place at 9:00 AM Eastern Time, where company management will discuss the financial results in detail. This session provides a valuable opportunity for investors and interested parties to gain insights into the company's performance and future outlook.
Innovative Approach to Life-Science Product Development
Evogene is dedicated to transforming the landscape of life-science product development. Utilizing advanced big data analytics and artificial intelligence, they focus on increasing the chances of success while minimizing the time and costs associated with bringing products to market.
Technological Innovations
The company has established three distinct tech-engines, each focused on a specific area within life sciences. These are:
- MicroBoost AI: This engine focuses on harnessing the power of microbes to enhance product efficacy.
- ChemPass AI: Dedicated to the development of small molecules, this tech-engine aims to create impactful ag-chemical solutions.
- GeneRator AI: Concentrating on genetic elements, this engine positions Evogene at the forefront of genetic innovation.
Strategic Partnerships and Subsidiaries
Evogene collaborates through strategic partnerships and operates four subsidiaries to advance its innovative vision:
- Biomica Ltd.: This subsidiary works on microbiome-based therapeutics that address human disorders.
- Lavie Bio Ltd.: Focused on commercializing microbiome-based agricultural products, Lavie Bio is essential to promoting sustainable agriculture.
- AgPlenus Ltd.: Specializing in the development of next-generation agricultural chemicals, AgPlenus aims to create sustainable crop protection solutions.
- Casterra Ag Ltd.: Dedicated to developing superior castor seed varieties for diverse industries, including biofuels, Casterra utilizes advanced breeding techniques.
Exploring the Future of Agri-tech
Evogene continues to lead in the field of agri-tech, focusing on research and practical applications that address contemporary challenges in agriculture. Through its subsidiaries and ongoing projects, the company is paving the way for the next generation of agricultural solutions.
Contact Information and Resources
To learn more about the upcoming financial results and company initiatives, interested individuals can visit the Evogene website for updates and further information.
For inquiries:
Tel: +972-8-9311901
Frequently Asked Questions
When will Evogene release its third quarter financial results?
Evogene is set to release its financial results on November 21, 2024.
What is the focus of Evogene's technology?
Evogene uses computational biology, big data, and artificial intelligence to innovate in life-science product development.
How can I join the conference call for the results?
Participants are encouraged to register in advance to join the conference call at 9:00 AM Eastern Time.
What are some of Evogene's subsidiaries?
Evogene operates Biomica Ltd., Lavie Bio Ltd., AgPlenus Ltd., and Casterra Ag Ltd., each focusing on distinct areas of life sciences and agriculture.
How can I get more information about Evogene?
For additional information, please visit Evogene’s official website.